Indo Us Bio Tech Limited has submitted a regulatory intimation to BSE Limited and the National Stock Exchange of India Limited regarding an upcoming meeting of its Board of Directors.
The board meeting is scheduled to be held on Friday, 30th October, 2026. The primary agenda for this meeting is to consider, approve, and take on record the Un-Audited Standalone Financial Results of the Company for both the quarter and half year ended 30th September, 2026.
The notice also states that the board may consider any other matter with the permission of the chair. This disclosure is made in compliance with Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.
No specific financial figures, performance metrics, or forward-looking guidance are disclosed in this intimation, as it serves solely as a notice for the upcoming board meeting where the results will be reviewed and approved.